Vertex 2 gm/vial (IV Injection)
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Orion pharma ltd |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
Ceftriaxone is a 3rd generation broad-spectrum parenteral cephalosporin antibiotic with potent bactericidal activity against a wide range of Gram-positive and Gram-negative organisms. It kills bacteria by interfering with the synthesis of the bacterial cell wall. Ceftriaxone has a relatively long plasma elimination half-life of about 6 to 9 hours, and is highly protein bound (95%).
Dosage
- Adult: 1 to 2 gm by intravenous or intramuscular administration once a day (or in equally divided doses twice a day)
- Maximum dose: 4 gm/day
- Children: 50 to 75 mg/kg intravenous or intramuscular administration once a day (or in equally divided doses twice a day)
- Usual duration of therapy is 4 to 14 days
Administration
- Intramuscular Injection:
- Dissolve 250 mg or 500 mg Ceftriaxone in 2 ml Lidocaine HCI 1% injection
- Dissolve 1 g Ceftriaxone in 3.5 ml of Lidocaine HCI 1% injection
- Intravenous Injection:
- Dissolve 250 mg or 500 mg Ceftriaxone in 5 ml of Water for injection
- Dissolve 1 g Ceftriaxone in 10 ml of Water for injection USP
- Dissolve 2 g Ceftriaxone in 20 ml of Water for injection
- Duration of Solution Stability: Maintains potency for at least 6 hours at room temperature or 24 hours at 5°C
Interaction
No drug interactions reported
Contraindications
Not for patients with a history of hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects
- Cutaneous reactions
- Hematologic reactions
- Hepatic reactions
- CNS reactions
- Local phlebitis after intravenous administration
Pregnancy & Lactation
Safety in human pregnancy not established; caution in lactating mothers
Precautions & Warnings
- Anaphylactic shock potential
- Sonogram findings related to gallbladder
- Regular blood picture checks during prolonged treatment
Use in Special Populations
Not for neonates if premature or newborn (up to 28 days of age)
Overdose Effects
No specific antidote. Symptomatic treatment recommended
Therapeutic Class
Third generation Cephalosporins
Storage Conditions
Store vial below 30°C, away from light and moisture